Minimum age of 11 set for UK puberty blocker trial

• Children must be at least 11 years old to participate in the UK's clinical trial of puberty-blocking drugs for gender-questioning youth
• This trial represents a formal research pathway to evaluate the safety and efficacy of puberty blockers in this population
• The age threshold reflects regulatory and ethical considerations for including minors in pharmaceutical research on gender-affirming treatments

Gender-questioning children will have to be at least 11 years old to take part in a clinical trial of puberty-blocking drugs.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.